🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3389404 is being developed for the treatment of CHB virus infection. The...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-14
Trial ID
NCT03020745
Treatments Being Tested
This study will test the safety, tolerability and blood concentrations of s...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-06-13
Trial ID
NCT02793232
The purpose of the study is to assess the safety, tolerability, pharmacokin...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01964872
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multipl...
Status
Active Not Recruiting
Location
Medpace Clinical Pharmacology
Start Date
2025-10-23
Trial ID
NCT07223216
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, pharmacokine...
Status
Completed
Location
Clinical Research Hospital Tokyo
Start Date
2018-10-09
Trial ID
NCT03687684
The primary purpose of Part 1 in this study is to assess the safety and tol...
Status
Completed
Location
Arizona Research Center
Start Date
2017-11-13
Trial ID
NCT03251482
The goal of this clinical study is to learn more about the study drug, GS-4...
Status
Recruiting
Location
Qps-Mra, Llc.
Start Date
2024-08-28
Trial ID
NCT06562907
Treatments Being Tested
The primary purpose of this study is to evaluate the safety, tolerability, ...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01193478
The purpose of the study is to evaluate the safety, tolerability, pharmacok...
Status
Recruiting
Location
Research Site
Start Date
2025-05-27
Trial ID
NCT06980428
The purpose of the study is to evaluate safety, tolerability, and pharmacok...
Status
Completed
Location
Joe DiMaggio Cycstic Fibrosis & Pulmonary Center
Start Date
2023-12-12
Trial ID
NCT06154447
Treatments Being Tested